Bcop Study Guide 2026-2027: A Complete Review of Oncology Pharmacy with Exam Style Questions and Rationales (Paperback) (ISBN-13: 9798175587747)

BCOP(R) and Board Certified Oncology Pharmacist(R) are registered trademarks associated with the Board of Pharmacy Specialties (BPS). This publication is an independent educational resource and is not affiliated with, endorsed by, sponsored by, or approved by the Board of Pharmacy Specialties, the American Pharmacists Association, the American Society of Health-System Pharmacists, the American Society of Clinical Oncology, the National Comprehensive Cancer Network, or any other professional organization, certification body, educational institution, pharmaceutical company, or examination provider. All trademarks, service marks, organization names, company names, and product names referenced in this publication remain the property of their respective owners and are used solely for identification and educational purposes.

Oncology pharmacy demands more than memorizing drug names, regimens, and adverse effects. It requires you to connect cancer biology, biomarkers, pharmacotherapy, patient-specific factors, supportive care, medication safety, and clinical evidence-and make the right decision when the stakes are high. The BCOP Study Guide 2026-2027 was created to help pharmacists and pharmacy professionals develop exactly that kind of integrated understanding. Whether you are preparing for an oncology pharmacy certification-style examination, transitioning into oncology practice, or strengthening your advanced therapeutic knowledge, this comprehensive resource provides a structured path from foundational concepts to patient-centered clinical application. Instead of relying on disconnected facts, this guide emphasizes clinical reasoning. You'll learn to evaluate the malignancy and treatment setting, recognize relevant biomarkers and molecular findings, assess organ function and drug interactions, anticipate toxicity, identify supportive-care needs, and determine when an urgent safety intervention must come before the next treatment decision.

The content takes you through the major areas of oncology pharmacy, including:

• Cancer biology, carcinogenesis, genetics, genomics, biomarkers, pathology, staging, prognosis, and performance status

• Cytotoxic chemotherapy, including mechanisms, cell-cycle effects, core toxicities, and monitoring considerations

• Targeted therapies, monoclonal antibodies, antibody-drug conjugates, immunotherapy, and cellular therapy

• Pharmacokinetics, pharmacogenomics, drug interactions, dose adjustment, and therapeutic monitoring

• Disease-specific treatment principles for solid tumors and hematologic malignancies

• Hematopoietic cell transplantation and graft-versus-host disease

• Supportive care, including myelosuppression, febrile neutropenia, antiemesis, pain, mucositis, nutrition, and gastrointestinal complications

• Critical oncologic emergencies, including tumor lysis syndrome and hypercalcemia

• Hazardous-drug handling, sterile compounding, chemotherapy verification, dose calculations, and medication safety

• Clinical trials, biostatistics, evidence appraisal, pharmacoeconomics, ethics, regulatory practice, and quality improvement

• Integrated final review strategies designed for timed oncology certification-style questions.